⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iiib lung cancer ajcc v8

Every month we try and update this database with for stage iiib lung cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac ChangesNCT04183218
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Localized Esoph...
Localized Lung ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Biospecimen Col...
Cardiac Event M...
Chemoradiothera...
Radiation Thera...
18 Years - Mayo Clinic
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung CancerNCT04751747
Locally Advance...
Metastatic Lung...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Computed Tomogr...
Contrast Agent
18 Years - Rutgers, The State University of New Jersey
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerNCT05498389
Metastatic Lung...
Advanced Lung N...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
EGFR Mutation-R...
EMB-01
Osimertinib
18 Years - Shanghai EpimAb Biotherapeutics Co., Ltd.
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With ImmunotherapyNCT03965689
Metastatic Lung...
Metastatic Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Carboplatin
Paclitaxel
Pevonedistat
18 Years - National Cancer Institute (NCI)
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerNCT03939481
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Lung Non-Small ...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage I Lung Ca...
Stage I Ovarian...
Stage IA Ovaria...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage IB Ovaria...
Stage IC Ovaria...
Stage II Lung C...
Stage II Ovaria...
Stage IIA Lung ...
Stage IIA Ovari...
Stage IIB Lung ...
Stage IIB Ovari...
Stage III Lung ...
Stage III Ovari...
Stage IIIA Lung...
Stage IIIA Ovar...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Lung...
Stage IIIB Ovar...
Stage IIIC Lung...
Stage IIIC Ovar...
Chemotherapy
Functional Asse...
Questionnaire A...
18 Years - SWOG Cancer Research Network
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerNCT04181060
Advanced Lung N...
Metastatic Lung...
Recurrent Lung ...
Stage IIIB Lung...
Stage IV Lung C...
Bevacizumab
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Magnetic Resona...
Multigated Acqu...
Osimertinib
18 Years - National Cancer Institute (NCI)
Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung CancerNCT04073745
Lung Non-Small ...
Positive Surgic...
Resected Mass
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Quality-of-Life...
Questionnaire A...
Stereotactic Bo...
18 Years - Roswell Park Cancer Institute
Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT TrialNCT05339022
Advanced Lung N...
Advanced Lung S...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Best Practice
Exercise Interv...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung CancerNCT05017025
Advanced Lung N...
Metastatic Lung...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Aurora A Kinase...
Osimertinib
18 Years - M.D. Anderson Cancer Center
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesNCT02419495
Advanced Malign...
Clinical Stage ...
Clinical Stage ...
Fallopian Tube ...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Rena...
Ovarian Carcino...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Primary Periton...
Stage III Lung ...
Stage III Renal...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Lung ...
Stage IVB Lung ...
Triple-Negative...
Unresectable Lu...
Unresectable Me...
Unresectable Re...
Capecitabine
Carboplatin
Cyclophosphamid...
Doxorubicin
Eribulin
Fluorouracil
Ipilimumab
Irinotecan Hydr...
Leucovorin Calc...
Nivolumab
Olaparib
Oxaliplatin
Paclitaxel
Pembrolizumab
Pemetrexed
Selinexor
Topotecan
18 Years - M.D. Anderson Cancer Center
Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesNCT03590054
Stage III Cutan...
Stage IV Cutane...
Locally Advance...
Locally Advance...
Metastatic Head...
Metastatic Mali...
Metastatic Mela...
Metastatic Urot...
Non-Small Cell ...
Stage IB Lung C...
Stage III Cutan...
Stage III Lung ...
Stage III Urete...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Cutane...
Stage IV Lung C...
Stage IV Ureter...
Stage IVA Lung ...
Stage IVB Lung ...
Abexinostat
Pembrolizumab
18 Years - University of California, San Francisco
Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 NegativeNCT04929041
Lung Adenocarci...
Lung Adenosquam...
Lung Non-Small ...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Biopsy
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
Positron Emissi...
Quality-of-Life...
Stereotactic Bo...
18 Years - National Cancer Institute (NCI)
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyNCT04430725
Lung Non-Small ...
Metastatic Colo...
Metastatic Sarc...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Colore...
Stage IV Lung C...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
Computed Tomogr...
Microwave Ablat...
Questionnaire A...
Wedge Excision
18 Years - M.D. Anderson Cancer Center
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738
Stage IB Lung N...
Stage II Lung N...
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIA Lung...
Stage IIIB Lung...
Biospecimen Col...
Carboplatin
Cisplatin
Clinical Observ...
Computed Tomogr...
Crizotinib
Cytology Specim...
Echocardiograph...
Erlotinib
Gemcitabine Hyd...
Nivolumab
Paclitaxel
Pembrolizumab
Pemetrexed
Pemetrexed Diso...
Placebo Adminis...
Positron Emissi...
18 Years - National Cancer Institute (NCI)
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-ImmunotherapyNCT04372927
Locally Advance...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Cisplatin
Durvalumab
Etoposide
Hypofractionate...
Pemetrexed
18 Years - University of Washington
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerNCT02983578
Advanced Colore...
Advanced Lung N...
Lung Non-Small ...
Mismatch Repair...
Refractory Colo...
Refractory Lung...
Refractory Panc...
Stage II Pancre...
Stage III Color...
Stage III Lung ...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIC Colo...
Stage IIIC Lung...
Stage IV Colore...
Stage IV Lung C...
Stage IV Pancre...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
Danvatirsen
Durvalumab
18 Years - M.D. Anderson Cancer Center
Resiliency Among Older Adults Receiving Lung Cancer TreatmentNCT04229381
Advanced Lung C...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung CancerNCT05136846
Locally Advance...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Unresectable Lu...
Carboplatin
Durvalumab
Paclitaxel
Papaverine
Radiation Thera...
Pemetrexed
18 Years - Ohio State University Comprehensive Cancer Center
Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic CancerNCT03776253
Advanced Lung C...
Malignant Femal...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Psychosocial Ca...
Questionnaire A...
- City of Hope Medical Center
Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung CancerNCT05340309
Lung Non-Small ...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Atezolizumab an...
Survey Administ...
18 Years - University of Southern California
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their CaregiversNCT03948100
Esophageal Carc...
Lung Non-Small ...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Educational Int...
Quality-of-Life...
Questionnaire A...
Yoga
18 Years - M.D. Anderson Cancer Center
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerNCT03939481
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Lung Non-Small ...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage I Lung Ca...
Stage I Ovarian...
Stage IA Ovaria...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage IB Ovaria...
Stage IC Ovaria...
Stage II Lung C...
Stage II Ovaria...
Stage IIA Lung ...
Stage IIA Ovari...
Stage IIB Lung ...
Stage IIB Ovari...
Stage III Lung ...
Stage III Ovari...
Stage IIIA Lung...
Stage IIIA Ovar...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Lung...
Stage IIIB Ovar...
Stage IIIC Lung...
Stage IIIC Ovar...
Chemotherapy
Functional Asse...
Questionnaire A...
18 Years - SWOG Cancer Research Network
Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung CancerNCT04013542
ALK Gene Rearra...
EGFR Gene Mutat...
Locally Advance...
Lung Non-Small ...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Unresectable Lu...
Ipilimumab
Nivolumab
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyNCT03707574
Advanced Malign...
Advanced Melano...
Advanced Renal ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Color...
Stage III Lung ...
Stage III Ovari...
Stage III Prost...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIC Colo...
Stage IIIC Lung...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IV Colore...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IVA Color...
Stage IVA Lung ...
Stage IVA Ovari...
Stage IVA Prost...
Stage IVB Color...
Stage IVB Lung ...
Stage IVB Ovari...
Stage IVB Prost...
Stage IVC Color...
Biospecimen Col...
18 Years - National Cancer Institute (NCI)
Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung CancerNCT04479306
Recurrent Lung ...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Alisertib
Osimertinib
Sapanisertib
18 Years - M.D. Anderson Cancer Center
Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their CaregiversNCT03902535
Caregiver
Head and Neck C...
Lung Carcinoma
Metastatic Head...
Metastatic Lung...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Comprehensive G...
Quality-of-Life...
Questionnaire A...
21 Years - City of Hope Medical Center
Remote Monitoring With Health-Coaching for Lifestyle Changes in Patients With Lung Cancer Related FatigueNCT05407038
Advanced Lung N...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Exercise Counse...
Exercise Interv...
Internet-Based ...
Interview
Medical Device ...
Questionnaire A...
18 Years - Mayo Clinic
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNCT04705025
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Lung Non-Small ...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Cognitive Behav...
Interview
Quality-of-Life...
Questionnaire A...
18 Years - Jonsson Comprehensive Cancer Center
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaNCT04940299
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Malignant Solid...
Metastatic Blad...
Metastatic Blad...
Metastatic Lung...
Metastatic Mela...
Metastatic Rena...
Metastatic Uret...
Metastatic Uret...
Metastatic Uret...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage III Urete...
Stage III Ureth...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IV Ureter...
Stage IV Urethr...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Me...
Ipilimumab
Nivolumab
Tocilizumab
18 Years - M.D. Anderson Cancer Center
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738
Stage IB Lung N...
Stage II Lung N...
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIA Lung...
Stage IIIB Lung...
Biospecimen Col...
Carboplatin
Cisplatin
Clinical Observ...
Computed Tomogr...
Crizotinib
Cytology Specim...
Echocardiograph...
Erlotinib
Gemcitabine Hyd...
Nivolumab
Paclitaxel
Pembrolizumab
Pemetrexed
Pemetrexed Diso...
Placebo Adminis...
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST TrialNCT04267848
Lung Non-Small ...
Lung Non-Small ...
Lung Non-Squamo...
Stage II Lung C...
Stage IIIA Lung...
Stage IIIB Lung...
Biospecimen Col...
Carboplatin
Cisplatin
Computed Tomogr...
Echocardiograph...
Gemcitabine Hyd...
Magnetic Resona...
Observation
Paclitaxel
Pembrolizumab
Pemetrexed Diso...
Quality-of-Life...
Questionnaire A...
18 Years - National Cancer Institute (NCI)
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung CancerNCT05136846
Locally Advance...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Unresectable Lu...
Carboplatin
Durvalumab
Paclitaxel
Papaverine
Radiation Thera...
Pemetrexed
18 Years - Ohio State University Comprehensive Cancer Center
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and LungNCT05412875
Head and Neck S...
Lung Non-Small ...
Stage I Cutaneo...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Cutane...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Cutan...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Cutane...
Best Practice
Nicotine Replac...
Quality-of-Life...
Questionnaire A...
21 Years - Ohio State University Comprehensive Cancer Center
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung CancerNCT03995667
Extensive Stage...
Limited Stage L...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Questionnaire A...
Tumor Treating ...
22 Years - OHSU Knight Cancer Institute
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint InhibitorsNCT05334329
Advanced Lung N...
Metastatic Lung...
Recurrent Lung ...
Refractory Lung...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Antineoplastic ...
Atezolizumab
Biospecimen Col...
Cyclophosphamid...
Fludarabine
18 Years - City of Hope Medical Center
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung CancerNCT04092283
Recurrent Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Unresectable Lu...
Carboplatin
Cisplatin
Durvalumab
Etoposide
Paclitaxel
Pemetrexed Diso...
18 Years - National Cancer Institute (NCI)
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerNCT03793179
Lung Non-Squamo...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Biospecimen Col...
Carboplatin
Computed Tomogr...
Magnetic Resona...
Pembrolizumab
Pemetrexed
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 NegativeNCT04929041
Lung Adenocarci...
Lung Adenosquam...
Lung Non-Small ...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Biopsy
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
Positron Emissi...
Quality-of-Life...
Stereotactic Bo...
18 Years - National Cancer Institute (NCI)
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung CancerNCT03995667
Extensive Stage...
Limited Stage L...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Questionnaire A...
Tumor Treating ...
22 Years - OHSU Knight Cancer Institute
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung CancerNCT04971187
Locally Advance...
Metastatic Lung...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Bintrafusp Alfa
Pemetrexed
Carboplatin
Cisplatin
18 Years - M.D. Anderson Cancer Center
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung CancerNCT04092283
Recurrent Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Unresectable Lu...
Carboplatin
Cisplatin
Durvalumab
Etoposide
Paclitaxel
Pemetrexed Diso...
18 Years - National Cancer Institute (NCI)
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung CancerNCT04067830
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Best Practice
Laparoscopic Su...
Quality-of-Life...
Questionnaire A...
Respiratory Mus...
Video-Assisted ...
18 Years - Roswell Park Cancer Institute
Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLCNCT04227028
Locally Advance...
Metastatic Lung...
Recurrent Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Bevacizumab
Brigatinib
18 Years - City of Hope Medical Center
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Colitis
Lung Non-Small ...
Malignant Genit...
Malignant Solid...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Best Practice
Biospecimen Col...
Endoscopic Proc...
Fecal Microbiot...
Infliximab
Laboratory Biom...
Prednisone
Vedolizumab
18 Years - M.D. Anderson Cancer Center
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerNCT05498389
Metastatic Lung...
Advanced Lung N...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
EGFR Mutation-R...
EMB-01
Osimertinib
18 Years - Shanghai EpimAb Biotherapeutics Co., Ltd.
Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung CancerNCT04262869
Lung Non-Small ...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Carboplatin
Durvalumab
Paclitaxel
Pemetrexed
18 Years - Emory University
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesNCT04902040
Advanced Bladde...
Advanced Lung N...
Advanced Malign...
Advanced Melano...
Advanced Merkel...
Advanced Renal ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Bladd...
Stage IVA Lung ...
Stage IVB Bladd...
Stage IVB Lung ...
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
Plinabulin
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine CarcinomasNCT04701307
Lung Small Cell...
Neuroendocrine ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Dostarlimab
Niraparib
18 Years - M.D. Anderson Cancer Center
Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT TrialNCT05339022
Advanced Lung N...
Advanced Lung S...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Best Practice
Exercise Interv...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center
Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialNCT06096844
Advanced Lung N...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Biospecimen Col...
Carboplatin
Computed Tomogr...
Magnetic Resona...
Nab-paclitaxel
Paclitaxel
Pembrolizumab
Pemetrexed
Positron Emissi...
Quality-of-Life...
Questionnaire A...
70 Years - National Cancer Institute (NCI)
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesNCT04902040
Advanced Bladde...
Advanced Lung N...
Advanced Malign...
Advanced Melano...
Advanced Merkel...
Advanced Renal ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Bladd...
Stage IVA Lung ...
Stage IVB Bladd...
Stage IVB Lung ...
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
Plinabulin
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerNCT03793179
Lung Non-Squamo...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Biospecimen Col...
Carboplatin
Computed Tomogr...
Magnetic Resona...
Pembrolizumab
Pemetrexed
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized ChemoradiationNCT05010109
Locally Advance...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
6 Minute Walk F...
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Exercise Cardia...
Questionnaire A...
Single Photon E...
18 Years - M.D. Anderson Cancer Center
Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 TherapyNCT04892953
Stage III Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Carboplatin
Durvalumab
Gemcitabine
Local Consolida...
Nab-paclitaxel
Paclitaxel
Pemetrexed
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME StudyNCT05022394
Lung Non-Small ...
Recurrent Lung ...
Stage I Lung Ca...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Nivolumab
Sapanisertib
18 Years - M.D. Anderson Cancer Center
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNCT04705025
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Lung Non-Small ...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Cognitive Behav...
Interview
Quality-of-Life...
Questionnaire A...
18 Years - Jonsson Comprehensive Cancer Center
Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing TreatmentNCT03731585
Non-Small Cell ...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Behavioral Inte...
Educational Int...
Questionnaire A...
Support Group T...
18 Years - M.D. Anderson Cancer Center
Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialNCT06096844
Advanced Lung N...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Biospecimen Col...
Carboplatin
Computed Tomogr...
Magnetic Resona...
Nab-paclitaxel
Paclitaxel
Pembrolizumab
Pemetrexed
Positron Emissi...
Quality-of-Life...
Questionnaire A...
70 Years - National Cancer Institute (NCI)
Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT TrialNCT05339022
Advanced Lung N...
Advanced Lung S...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Best Practice
Exercise Interv...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center
Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and ToxicityNCT04954885
Lung Non-Squamo...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Biospecimen Col...
Physical Perfor...
Physical Perfor...
Questionnaire A...
18 Years - Ohio State University Comprehensive Cancer Center
Resiliency Among Older Adults Receiving Lung Cancer TreatmentNCT04229381
Advanced Lung C...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center
Family Caregivers in Underserved Populations Providing Complex Cancer CareNCT05213078
Malignant Femal...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Educational Int...
Quality-of-Life...
Questionnaire A...
18 Years - City of Hope Medical Center
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint InhibitorsNCT05334329
Advanced Lung N...
Metastatic Lung...
Recurrent Lung ...
Refractory Lung...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Antineoplastic ...
Atezolizumab
Biospecimen Col...
Cyclophosphamid...
Fludarabine
18 Years - City of Hope Medical Center
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and LungNCT05412875
Head and Neck S...
Lung Non-Small ...
Stage I Cutaneo...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Cutane...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Cutan...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Cutane...
Best Practice
Nicotine Replac...
Quality-of-Life...
Questionnaire A...
21 Years - Ohio State University Comprehensive Cancer Center
Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung CancerNCT04479306
Recurrent Lung ...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Alisertib
Osimertinib
Sapanisertib
18 Years - M.D. Anderson Cancer Center
A Nurse-Led Intervention for Fear of Progression in Advanced CancerNCT04819997
Advanced Lung C...
Metastatic Mali...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Educational Int...
- City of Hope Medical Center
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With ImmunotherapyNCT03965689
Metastatic Lung...
Metastatic Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Carboplatin
Paclitaxel
Pevonedistat
18 Years - National Cancer Institute (NCI)
Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsNCT03867916
Caregiver
Malignant Neopl...
Physician
Stage I Colorec...
Stage I Liver C...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Colore...
Stage II Liver ...
Stage II Lung C...
Stage IIA Color...
Stage IIA Lung ...
Stage IIB Color...
Stage IIB Lung ...
Stage IIC Color...
Stage III Color...
Stage III Liver...
Stage III Lung ...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIC Colo...
Stage IIIC Lung...
Patient Navigat...
Quality-of-Life...
Survey Administ...
21 Years - University of California, San Francisco
Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR StudyNCT03410043
Lung Non-Small ...
Recurrent Lung ...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Osimertinib
Radiation Thera...
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center
Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR StudyNCT03410043
Lung Non-Small ...
Recurrent Lung ...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Osimertinib
Radiation Thera...
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center
Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their CaregiversNCT04662645
Caregiver
Malignant Pleur...
Metastatic Thym...
Recurrent Lung ...
Recurrent Thymi...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Palliative Ther...
Questionnaire A...
18 Years - Ohio State University Comprehensive Cancer Center
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Colitis
Lung Non-Small ...
Malignant Genit...
Malignant Solid...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Best Practice
Biospecimen Col...
Endoscopic Proc...
Fecal Microbiot...
Infliximab
Laboratory Biom...
Prednisone
Vedolizumab
18 Years - M.D. Anderson Cancer Center
Remote Monitoring With Health-Coaching for Lifestyle Changes in Patients With Lung Cancer Related FatigueNCT05407038
Advanced Lung N...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Exercise Counse...
Exercise Interv...
Internet-Based ...
Interview
Medical Device ...
Questionnaire A...
18 Years - Mayo Clinic
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung CancerNCT04067830
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Best Practice
Laparoscopic Su...
Quality-of-Life...
Questionnaire A...
Respiratory Mus...
Video-Assisted ...
18 Years - Roswell Park Cancer Institute
Remote Monitoring With Health-Coaching for Lifestyle Changes in Patients With Lung Cancer Related FatigueNCT05407038
Advanced Lung N...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Exercise Counse...
Exercise Interv...
Internet-Based ...
Interview
Medical Device ...
Questionnaire A...
18 Years - Mayo Clinic
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738
Stage IB Lung N...
Stage II Lung N...
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIA Lung...
Stage IIIB Lung...
Biospecimen Col...
Carboplatin
Cisplatin
Clinical Observ...
Computed Tomogr...
Crizotinib
Cytology Specim...
Echocardiograph...
Erlotinib
Gemcitabine Hyd...
Nivolumab
Paclitaxel
Pembrolizumab
Pemetrexed
Pemetrexed Diso...
Placebo Adminis...
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung CancerNCT05136846
Locally Advance...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Unresectable Lu...
Carboplatin
Durvalumab
Paclitaxel
Papaverine
Radiation Thera...
Pemetrexed
18 Years - Ohio State University Comprehensive Cancer Center
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerNCT04428905
Lung Non-Small ...
Stage I Colorec...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Colore...
Stage II Lung C...
Stage IIA Color...
Stage IIA Lung ...
Stage IIB Color...
Stage IIB Lung ...
Stage IIC Color...
Stage III Color...
Stage III Lung ...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIC Colo...
Stage IIIC Lung...
Quality-of-Life...
Questionnaire A...
Survivorship Ca...
Telemedicine
18 Years - City of Hope Medical Center
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyNCT04430725
Lung Non-Small ...
Metastatic Colo...
Metastatic Sarc...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Colore...
Stage IV Lung C...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
Computed Tomogr...
Microwave Ablat...
Questionnaire A...
Wedge Excision
18 Years - M.D. Anderson Cancer Center
[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed TherapyNCT04186988
Advanced Lung N...
Metastatic Lung...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Fluorine F 18 A...
18 Years - University of California, Davis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: